-
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy
Tuesday, February 7, 2023 - 5:44pm | 435Clinical-stage biopharma psychedelics company Seelos Therapeutics Inc. (NASDAQ: SEEL) announced it has dosed the first patients in a Phase 1 study with healthy adult Japanese and non-Asian participants to compare the safety and pharmacokinetic (PK) profiles of proprietary intranasal racemic...
-
Seelos Therapeutics' SLS-002 Shows Clinically Meaningful Efficacy As Anti-Depressive, Anti-Suicidal Therapeutic After Single Dose
Monday, May 17, 2021 - 9:17am | 221Seelos Therapeutics Inc (NASDAQ: SEEL) has announced data from Part 1, the open-label cohort, of its Proof-of-Concept study of SLS-002 for acute suicidal ideation and behavior in patients with Major Depressive Disorder. On depression scale, 76.5% response rate on Day 1 (n=17),...
-
Moody's Mark Zandi Says US Economy Might Enter Depression If Second Coronavirus Wave Begins
Monday, May 11, 2020 - 7:03am | 448Moody’s Analytics chief economist Mark Zandi has warned that the U.S. economy risks a depression should individual states gamble on reopening businesses too soon. Make Or Break Moment Zandi, who sits on the board of MGIC, one of the largest private mortgage insurance companies, appeared...
-
This Drug, An Alternative To Marijuana And Ketamine, Could Treat Suicidal Depression And PTSD
Thursday, September 7, 2017 - 1:02pm | 980It's hard to forget the feeling that took over the world when Robin Williams committed suicide. To think that “someone that successful, that funny, that rich, who has entertained so many ... could be so low as to take his own life is incomprehensible,” Larry King said at the time,...